Skip to content
Screener

MiMedx Group MDXG Q2 2026 earnings

Reported July 29, 2026 · After market close

Revenue$64.4MBeat by $901.6K
EPS-$0.05Miss by $0.00
Revenue estimate$63.5M
EPS estimate-$0.05
“During the second quarter, we delivered another strong performance in our Surgical franchise, with 15% year-over-year revenue growth balanced across our sheet and particulate products. Our sustained momentum in several Surgical settings represents a meaningful, long-term growth opportunity for the Company, and we are focused on expanding into other procedures.”
Joseph H. Capper

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$69.6M
EPS estimate$0.01

Financials

Q2 2026

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%
EPS (diluted)-$0.10-267%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total equity$216.0M-0.3%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
CapEx$598.0K+234%
Free cash flow-$10.6M-175%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$690.27M-32.8%
Enterprise value$571.64M-38.3%
P/E110.6×+78.7×
P/S1.9×-0.9×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Segments

By product

See full
Surgical$39.3M+15.1%
Wound$25.1M-61.1%

FAQ

When did MiMedx Group report Q2 2026 earnings?
MiMedx Group (MDXG) reported Q2 2026 earnings on July 29, 2026 after market close.
What were MiMedx Group's Q2 2026 revenue and EPS?
MiMedx Group reported revenue of $64.4M and eps of $-0.05 for Q2 2026.
Did MiMedx Group beat estimates in Q2 2026?
Revenue beat the consensus estimate of $63.5M by $901.6K. EPS missed the consensus estimate of $-0.05 by $0.00.
How did MiMedx Group's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 34.7% from $98.6M a year earlier.
Where can I find MiMedx Group's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001376339-26-000070) and the 10-Q periodic report (0001376339-26-000071) directly on SEC EDGAR. The filing index links above go to sec.gov.